Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from IVERIC bio

Biotech Buying Bonanza: Iveric Bio Snags $5.9 Billion Deal From Astellas Pharma

Astellas Pharma snapped up Iveric Bio for $5.9 billion in cash, the companies said Monday in an announcement that sent ISEE stock flying.

Investors Business Daily

Apellis Pharma Crashes On Unexpected Delay For Eye Drug, Taking A Key Rival With It

Apellis Pharma Crashes On Unexpected Delay For Eye Drug, Taking A Key Rival With It

Apellis reported an unexpected delay for its eye-disease treatment, leading APLS stock to crash and taking shares of Iveric with it.

Investors Business Daily

12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Intraday Session

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

12 Health Care Stocks Moving In Thursday's Intraday Session

Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2022

IVERIC bio: Q1 Earnings Insights

IVERIC bio (NASDAQ:ISEE) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings IVERIC bio reported in-line EPS of $-0.29 versus an estimate of $-0.29.

inkl

Read news from The Economist, FT, and more,
with one subscription

IVERIC bio Earnings Conference Call Is Coming Up, Here's What You Need To Know

IVERIC bio Earnings Conference Call Is Coming Up, Here's What You Need To Know

IVERIC bio (NASDAQ:ISEE) will host a conference call at 08:00 AM ET on May 4, 2022, to discuss Q1 2022 earnings results. How to Attend IVERIC bio (ISEE) Conference Call Follow this link to access the live webcast.

Benzinga's Top Ratings Upgrades, Downgrades For March 22, 2022

Benzinga's Top Ratings Upgrades, Downgrades For March 22, 2022

Earnings Outlook For IVERIC bio

Earnings Outlook For IVERIC bio

IVERIC bio (NASDAQ:ISEE) is set to give its latest quarterly earnings report on Thursday, 2022-02-24. Here's what investors need to know before the announcement. Analysts estimate that IVERIC bio will report an earnings per share (EPS) of $-0.24.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

American Express

Rivian Automotive

ON Semiconductor

B of A Securities

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play